Insider · CIK 0001797804
Sandra Niewiem
Files at OEC (Orion S.A.). First filing -, latest -.
Sandra Niewiem files SEC Form 4 as officer at OEC (Orion S.A.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sandra Niewiem has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | OEC Orion S.A. | FTax withholding Common Shares, no par value | -2,662 | $6.27 | $17k | 24,255 | Feb 23, 2026 |
| Feb 19, 2026 | OEC Orion S.A. | AGrant or award Common Shares, no par value | +5,952 | $0.00 | $0 | 30,207 | Feb 23, 2026 |
| Feb 19, 2026 | OEC Orion S.A. | FTax withholding Common Shares, no par value | -2,827 | $6.27 | $18k | 27,380 | Feb 23, 2026 |
| May 5, 2025 | OEC Orion S.A. | AGrant or award Common Shares, no par value | +7,098 | $0.00 | $0 | 26,917 | May 7, 2025 |
Questions about Sandra Niewiem
Answered from the filings on this page, as of the latest one.
Is Sandra Niewiem buying or selling?
Sandra Niewiem has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sandra Niewiem's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sandra Niewiem has 0.
Where does Sandra Niewiem file Form 4?
Sandra Niewiem has filed Form 4 at OEC (Orion S.A.) as Sr. VP Global Specialties. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.